(Q61967845)

English

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

clinical trial

Statements

A Phase II Study of the c-Met Inhibitor ARQ 197 in Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma (English)
0 references
November 2011
0 references
March 2014
0 references
16
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit